Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases
article
OA: closed
CC0
⤵ 37 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Inhibition of prostaglandin E2 receptors EP2 and EP4 suppresses metalloproteinases, thereby reducing invasion by human immortalized endometriotic epithelial and stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (83)
- Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms via openalex
- Differential induction of matrix metalloproteinase 1 and 2 in ectopic endometrium via openalex
- Down-Regulation of Endometrial Matrix Metalloproteinase-3 and -7 Expression<i>in Vitro</i>and Therapeutic Regression of Experimental Endometriosis<i>in Vivo</i>by a Novel Nonsteroidal Progesterone Receptor Agonist, Tanaproget via openalex
- Endometriosis via openalex
- Endometriosis: disease pathophysiology and the role of prostaglandins via openalex
- Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2 via openalex
- Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 via openalex
- Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis via openalex
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis via openalex
- Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis via openalex
- Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis via openalex
- Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis via openalex
- Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients via openalex
- Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis via openalex
- Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans via openalex
- Matrix metalloproteinase-13 and membrane type-1 matrix metalloproteinase in peritoneal fluid of women with endometriosis via openalex
- Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Matrix metalloproteinases 2 and 9, E-cadherin, and β-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium via openalex
- Matrix Metalloproteinases and Endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
- The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis via openalex
- Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells via openalex
- Vascular endothelial growth factor and matrix metalloproteinase-2 expedite formation of endometriosis in the early stage ICR mouse model via openalex
- W2121612337 via openalex
- W2122365868 via openalex
- W2127607312 via openalex
- W2128635872 via openalex
- W2133223726 via openalex
- W2151824014 via openalex
- W2152039407 via openalex
- W2156490866 via openalex
- W2164579284 via openalex
- W2258579859 via openalex
- W2284252171 via openalex
- W2362499251 via openalex
- W4211081176 via openalex
- W4293247451 via openalex
- W6636715071 via openalex
- W6676706335 via openalex
- W6695727498 via openalex
- W6707214820 via openalex
- W1519720742 via openalex
- W1635873859 via openalex
- W1969169755 via openalex
- W1970002473 via openalex
- W1974701693 via openalex
- W1975593847 via openalex
- W1981263394 via openalex
- W1983921365 via openalex
- W1985990006 via openalex
- W1986115109 via openalex
- W1986127555 via openalex
- W1991266606 via openalex
- W1991453413 via openalex
- W1997891155 via openalex
- W2003556265 via openalex
- W2004307784 via openalex
- W2012551574 via openalex
- W2028413004 via openalex
- W2040095832 via openalex
- W2041767365 via openalex
- W2043521546 via openalex
- W2058018225 via openalex
- W2067427710 via openalex
- W2067837272 via openalex
- W2070426889 via openalex
- W2071647022 via openalex
- W2078935333 via openalex
- W2087175325 via openalex
- W2093492520 via openalex
- W2108787980 via openalex
- W2113437765 via openalex
- W2117787209 via openalex
Cited by (37)
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis 2022
- Associations between Exposure to Organochlorine Chemicals and Endometriosis: A Systematic Review of Experimental Studies and Integration of Epidemiological Evidence 2021
- Effects of dual inhibition of AKT and ERK1/2 pathways on endometrial pro-inflammatory, hormonal, and epigenetic microenvironment in endometriosis 2021
- PPARγ Agonists: Emergent Therapy in Endometriosis 2021
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Multiple Roles of Prostaglandin E2 Receptors in Female Reproduction 2020
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages 2020
- The role of matrix metalloproteinases in the pathogenesis of endometriosis(literature review) 2020
- MicroRNAs in endometriosis: biological function and emerging biomarker candidates† 2019
- GLI1 is increased in ovarian endometriosis and regulates migration, invasion and proliferation of human endometrial stromal cells in endometriosis 2019
- Aldo-keto reductase 1C3—Assessment as a new target for the treatment of endometriosis 2019
- Cyclooxygenase-2 in Endometriosis 2019
- Dual inhibition of ERK1/2 and AKT pathways is required to suppress the growth and survival of endometriotic cells and lesions 2018
- Decreased Expression of HOXA10 May Activate the Autophagic Process in Ovarian Endometriosis 2018
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- The DNA methylation status of genes encoding Matrix metalloproteinases and tissue inhibitors of Matrix metalloproteinases in endometriosis 2017
- The effect of prostaglandin E2 receptor (PTGER2) activation on growth factor expression and cell proliferation in bovine endometrial explants 2017
- Proteome-Wide Effect of 17-β-Estradiol and Lipoxin A4 in an Endometriotic Epithelial Cell Line 2016
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Enhanced cyclooxygenase-2 expression levels and metalloproteinase 2 and 9 activation by Hexachlorobenzene in human endometrial stromal cells 2016
- Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype 2016
- miR-191 Modulates Malignant Transformation of Endometriosis Through Regulating TIMP3 2015
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells 2015
- Dysregulation of Lysyl Oxidase Expression in Lesions and Endometrium of Women With Endometriosis 2015
- Endometriosis and possible inflammation markers 2015
- Abnormal Expression of Prostaglandins E2 and F2<i>α</i>Receptors and Transporters in Patients with Endometriosis 2015
- The Impact of Endometriosis across the Lifespan of Women: Foreseeable Research and Therapeutic Prospects 2015
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis 2015
- Macrophage Migration Inhibitory Factor Is Involved in Ectopic Endometrial Tissue Growth and Peritoneal-Endometrial Tissue Interaction In Vivo: A Plausible Link to Endometriosis Development 2014
- Possible effects of endometriosis-related immune events on reproductive function 2013
- Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway. 2013
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis 2013
- The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function 2013
- PPARγ Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling. 2013
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 2012
- Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway 2012
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:54.825375+00:00
License: CC0
· commercial use OK